Patient-derived tumor organoids are emerging as high-fidelity preclinical models for precision oncology, offering a way to test cancer treatments on three-dimensional cell clusters that mirror a patient’s specific disease. Recent research led by investigators at Weill Cornell Medicine demonstrates that these “avatars” can reliably predict treatment sensitivity, potentially expanding the pool of patients eligible for … Read more
Researchers at China Pharmaceutical University have developed a multisite bridging-mediated lateral flow immunoassay (mbLFIA) that detects mosquito-borne viruses like Chikungunya (CHIKV) with high sensitivity without the need for specialized laboratory equipment. According to a study published in Targetome on April 30, 2026, the method achieves a visual detection limit of 2 pmol·L−1, offering a portable … Read more
Hepatocellular carcinoma (HCC) is currently the third leading cause of cancer death, with patient outcomes hindered by late diagnosis and scarce early biomarkers. According to a 2026 review in the journal Gene Expression, advancements in multi-omics and liquid biopsy are shifting the clinical landscape by enabling more precise prognostic tracking and personalized immunotherapy selection, though … Read more
Directed evolution, a method for engineering enzymes by mimicking the natural process of selection, is shifting from a niche lab technique to a primary engine for industrial chemistry. According to Caltech’s Frances Arnold, who received the 2018 Nobel Prize in Chemistry for this work, the future of the field lies in integrating machine learning with … Read more
Researchers have identified a potential therapeutic pathway for Alzheimer’s disease by targeting DNA damage within brain neurons. A study published in FEBS Open Bio reports that the molecule KCL-286 successfully repairs neuronal DNA in mouse models, simultaneously reducing brain inflammation and abnormal immune activity associated with neurodegeneration. How does KCL-286 target Alzheimer’s disease? The drug … Read more
Researchers have identified that disrupted calcium (Ca²⁺) homeostasis drives cellular aging, with a study published in Nature Communications demonstrating that the antidepressant mianserin can extend both median and maximum lifespans in mice. By blocking the IP3R calcium release channel in the endoplasmic reticulum, the treatment reduces inflammation and restores DNA repair mechanisms linked to the … Read more
Biologists at the University of Minnesota have successfully engineered a synthetic cell, dubbed “SpudCell,” capable of performing core biological life cycles including nutrient intake, growth, DNA replication, and division. According to a preprint posted July 2 on bioRxiv, the cell is constructed entirely from non-living chemical components and functions with a 90,000-base-pair genome, significantly smaller … Read more
A blood test detecting circulating tumour DNA (ctDNA) after surgery can identify colorectal cancer patients most likely to benefit from adjuvant chemotherapy, according to research presented at the 2026 ESMO Gastrointestinal Cancers Congress. The Phase II GALAXY study, led by researchers from Hyogo Medical University and collaborators including the University of Oxford, found that patients … Read more
The U.S. Food and Drug Administration approved zenocutuzumab as a second-line therapy for NRG1-positive cholangiocarcinoma on May 8. According to results from the eNRGy phase 2 clinical trial published in the Journal of Clinical Oncology, the drug more than doubled the median progression-free survival to 9.2 months, compared to the approximately four months typically seen … Read more
A KFF tracking poll indicates that the future of public health may depend on addressing a “malleable middle” of Americans who express uncertainty about vaccine myths. As AI and social media usage grow, researchers suggest that the gap between misinformation and medical truth may widen for those without trusted healthcare providers. Why the “malleable middle” … Read more